drugset / Trial / NCT02698618

PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor

NCT02698618 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Ticagrelor has a protective effect on microcirculation during percutaneous coronary interventions in patients with Diabetes mellitus type II or in a pre-diabetic status.

Timeline

Start
2016-03
Primary completion
2017-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg —
Subject Ticagrelor Small molecule 90 mg —